Semax

Overview

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH). It is studied in laboratory environments for its potential neuroprotective, nootropic, and neuroregenerative properties in preclinical models such as laboratory rodents. Researchers use Semax to investigate its effects on brain-derived neurotrophic factor (BDNF) expression, cognitive function, and neural recovery processes.

Benefits

Recent preclinical studies suggest that Semax may help support cognitive function, enhance learning and memory, and provide neuroprotection in test subjects exposed to models of ischemia or stress. Research indicates that Semax may stimulate BDNF production and modulate neurotransmitter systems involved in attention and neuroplasticity.
Source: Andreeva LA, et al. Semax activates the expression of neurotrophic factors in the rat brain. Brain Research Bulletin, 2019.

Possible Side Effects

In laboratory studies, test subjects administered Semax may exhibit mild side effects such as temporary nasal irritation (when delivered intranasally) or slight restlessness-like behavior depending on the dosage and study duration. Effects can vary based on species, delivery route, and experimental conditions.
Source: Andreeva LA, et al., Brain Research Bulletin, 2019.

Dosage & Administration

Semax is typically administered via intranasal delivery or subcutaneous injection under approved laboratory research protocols. Typical research dosages range from 100 mcg to 500 mcg per administration, usually given once or twice daily depending on the study’s design, test species, and research goals.
For laboratory research use only. Not for human consumption.

Summary

Semax is a synthetic neuropeptide developed exclusively for laboratory research exploring neuroprotection, cognitive function, and neuroregeneration in preclinical models. Studies suggest it may help enhance BDNF expression and cognitive performance with mild side effects such as nasal irritation occasionally noted in test subjects. Semax is administered intranasally or by subcutaneous injection, with dosage and frequency tailored to each study’s goals and species.
Strictly for research purposes only. Not for human use.